Brief: New York State Approves Precipio’S Hemescreen For POL Clinical Use
18/11/2021 16:21
Nov 18 (Reuters) - Precipio Inc PRPO.O :
* NEW YORK STATE APPROVES PRECIPIO’S HEMESCREEN FOR POL
CLINICAL
USE
Source text for Eikon: GNX4tLRb5
Further company coverage: PRPO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Precipio
See all newsCancer diagnostics firm Precipio's Q2 revenue rises, adjusted EBITDA turns positive
Precipio Q1 revenue rises on higher pathology sales
Blood cancer diagnostics firm Precipio's prelim Q4 revenue rises 23%
Brief: Precipio Identifies Unauthorized Access To Isolated Storage No Operational Impact
Specialty cancer diagnostics firm Precipio Q3 revenue rises 30% driven by new customers